Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-Blind, Placebo-Controlled, Phase III Study to Investigate the Efficacy of Presurgical 9-valent HPV Vaccination in Women Treated With LEEP for CIN 2+ and Initially Invasive Cervical Cancer.

NCT03848039 is registered in ClinicalTrials.gov with Alessandro Ghelardi as lead sponsor.

NCT NCT03848039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03848039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-Blind, Placebo-Controlled, Phase III Study to Investigate the Efficacy of Presurgical 9-valent HPV Vaccination in Women Treated With LEEP for CIN 2+ and Initially Invasive Cervical Cancer.
Lead sponsor
Alessandro Ghelardi
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 31, 2020
Completion date
May 31, 2028
Enrollment
1,220 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia